cbdMD, Inc. (NYSEAMERICAN:YCBD) Sees Large Increase in Short Interest

cbdMD, Inc. (NYSEAMERICAN:YCBD) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 931,108 shares, an increase of 188.8% from the April 15th total of 322,354 shares. Based on an average daily volume of 6,453,086 shares, the short-interest ratio is presently 0.1 days. Approximately 9.5% of the company’s shares are sold short.

cbdMD Trading Down 5.3%

Shares of NYSEAMERICAN:YCBD traded down $0.04 on Friday, hitting $0.77. The company had a trading volume of 332,257 shares, compared to its average volume of 3,780,259. The firm’s 50-day simple moving average is $0.78 and its two-hundred day simple moving average is $0.88. cbdMD has a 1 year low of $0.47 and a 1 year high of $2.56.

Institutional Investors Weigh In On cbdMD

An institutional investor recently bought a new position in cbdMD stock. Jane Street Group LLC bought a new position in cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned 0.49% of cbdMD at the end of the most recent quarter. Hedge funds and other institutional investors own 7.18% of the company’s stock.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.